280 related articles for article (PubMed ID: 9591812)
1. Contact hypersensitivity to tixocortol pivalate.
Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
[TBL] [Abstract][Full Text] [Related]
2. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of contact allergy to corticosteroids in a Danish patient population.
Svendsen SV; Bach RO; Mortz CG
Contact Dermatitis; 2022 Sep; 87(3):273-279. PubMed ID: 35460519
[TBL] [Abstract][Full Text] [Related]
4. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
Lauerma AI; Tarvainen K; Forström L; Reitamo S
Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
[TBL] [Abstract][Full Text] [Related]
5. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
Isaksson M; Bruze M; Goossens A; Lepoittevin JP
Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
[TBL] [Abstract][Full Text] [Related]
6. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
Uter W; Geier J; Richter G; Schnuch A;
Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
[No Abstract] [Full Text] [Related]
7. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
Lauerma AI
Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
[TBL] [Abstract][Full Text] [Related]
8. Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group.
Bircher AJ; Thürlimann W; Hunziker T; Pasche-Koo F; Hunziker N; Perrenoud D; Elsner P; Schultheiss R
Dermatology; 1995; 191(2):109-14. PubMed ID: 8520055
[TBL] [Abstract][Full Text] [Related]
9. Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity.
Frankild S; Lepoittevin JP; Kreilgaard B; Andersen KE
Contact Dermatitis; 2001 Jan; 44(1):18-22. PubMed ID: 11156006
[TBL] [Abstract][Full Text] [Related]
10. Contact hypersensitivity to topical corticosteroids.
Burden AD; Beck MH
Br J Dermatol; 1992 Nov; 127(5):497-500. PubMed ID: 1467289
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid-induced contact dermatitis: a pragmatic approach.
English JS
Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
Shaw DW; Maibach HI
Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
[TBL] [Abstract][Full Text] [Related]
13. Pattern of corticosteroid allergy in Thailand.
Wattanakrai P; Temnithikul B; Pootongkam S
Dermatitis; 2010; 21(4):203-6. PubMed ID: 20646671
[TBL] [Abstract][Full Text] [Related]
14. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
[No Abstract] [Full Text] [Related]
15. Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014.
Pratt MD; Mufti A; Lipson J; Warshaw EM; Maibach HI; Taylor JS; Sasseville D; DeKoven JG; Zirwas MJ; Fransway AF; Mathias CG; Zug KA; DeLeo VA; Fowler JF; Marks JG; Storrs FJ; Belsito DV
Dermatitis; 2017; 28(1):58-63. PubMed ID: 28002236
[TBL] [Abstract][Full Text] [Related]
16. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
Mirshahpanah P; Maibach HI
Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
[TBL] [Abstract][Full Text] [Related]
17. Contact allergy to corticosteroids: Is the European baseline series sufficient?
Svendsen SV; Bindslev-Jensen C; Mortz CG
Contact Dermatitis; 2023 Oct; 89(4):277-283. PubMed ID: 37321366
[TBL] [Abstract][Full Text] [Related]
18. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
Bruze M; Bjorkner B; Dooms-Goossens A
Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
[TBL] [Abstract][Full Text] [Related]
19. Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. European Society of Contact Dermatitis.
Isaksson M; Brandão FM; Bruze M; Goossens A
Contact Dermatitis; 2000 Jul; 43(1):41-2. PubMed ID: 10902588
[No Abstract] [Full Text] [Related]
20. Contact dermatitis to topical medicaments: a retrospective chart review from the Ottawa Hospital Patch Test Clinic.
Spring S; Pratt M; Chaplin A
Dermatitis; 2012; 23(5):210-3. PubMed ID: 23010827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
